Clinical and pathological evidence demonstrates that COVID-19 frequently leads to the development of pneumonia, ranging from mild interstitial involvement to severe acute respiratory distress syndrome.
The retrieved literature consistently supports the statement that COVID-19 frequently leads to pneumonia. Multiple papers (e.g., [0], [1], [2], [3], [7], [10]) explicitly describe pneumonia as a common clinical manifestation and pathological feature of SARS-CoV-2 infection. There are no papers refuting this relationship. Therefore, the verdict is SUPPORTED.